Drug profile

The FDA adverse-event record for Cbd

49 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Cbd. See the species affected, top reactions, and outcomes below.

49
adverse-event reports
20.4%
death-coded share
Dog
most-reported species
9
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
49
Total Reports
10
Deaths Reported
20.4%
Death Rate

Active Ingredients

Cbd

Administration Routes

UnknownOralTopical

Species Affected

Dog 45
Cat 3
Other Canids 1

Most Affected Breeds

Retriever - Labrador 9
Shepherd Dog - German 4
Domestic Shorthair 2
Sheepdog - Shetland 2
Retriever - Golden 2
Dog (unknown) 2
Newfoundland 2
Chihuahua 2
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 2
Maltese 1

Most Reported Reactions

Lack of efficacy - NOS 9
Seizure NOS 7
Death by euthanasia 7
Drug dose administration interval too short 6
Lack of efficacy (ectoparasite) - flea 6
Ataxia 5
Urinary incontinence 5
Diarrhoea 3
Vomiting 3
Anaemia NOS 3
Intentional misuse 3
Inappropriate defecation 2

Outcome Breakdown

Ongoing
22 (44.9%)
Outcome Unknown
12 (24.5%)
Euthanized
7 (14.3%)
Recovered/Normal
5 (10.2%)
Died
3 (6.1%)

Cbd Adverse Event Insights

49 reports name Cbd; 10 recorded a death outcome (20.4% of reported events, not a population-level mortality rate). Active ingredient: Cbd. Administration routes: Unknown, Oral, Topical.

By species: Dog (45 reports), Cat (3 reports), Other Canids (1 reports). By breed: Retriever - Labrador (9), Shepherd Dog - German (4), Domestic Shorthair (2).

Leading clinical signs: Lack of efficacy - NOS (9), Seizure NOS (7), Death by euthanasia (7), Drug dose administration interval too short (6). Outcome, 49 coded reports: Ongoing leads at 44.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.